Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ariosa Diagnostics Inc.

Division of Roche
www.ariadx.com

Latest From Ariosa Diagnostics Inc.

US PTO's Patent Eligibility Guidance Draws Industry Plaudits, Request For More Specifics

BIO, PhRMA, Novartis, Amgen, and Genentech suggest revisions to guidance on hot-button issue of subject matter patent eligiblity; patent owners group says 'best approach' is to enact legislation to restore patent eligibility law.

Intellectual Property Legal Issues

Illumina Awarded $26.7m In Patent Row

The verdict resolves an intellectual property dispute in which Illumina alleged Ariosa was violating Illumina's patents on prenatal genetic testing technology.

Medical Device Diagnostics

Roche Eyes Liquid Biopsy As A Boost To Drug Development, Cancer Monitoring

Roche Molecular Diagnostic's top researcher, Walter Koch, discusses the promise of liquid biopsy following FDA's recent approval of its first liquid-biopsy companion diagnostic, Roche's cobas test for the cancer drug Tarceva.

BioPharmaceutical Medical Device

Roche Eyes Liquid Biopsy As A Boost To Drug Development, Cancer Monitoring

The Gray Sheet spoke to Roche Molecular Diagnostic's top researcher, Walter Koch, about the promise of liquid biopsy soon after FDA approved its first liquid-biopsy companion diagnostic, Roche's cobas test for the cancer drug Tarceva.

Medical Device Strategy
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services
  • Services
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • Aria Diagnostics Inc.
  • Tandem Technologies Inc.
  • Tandem Diagnostics
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Roche
  • Senior Management
  • Dan Puckett, CFO
    Arnold Oliphant, PhD, CSO
    Thomas Musci, MD, CMO
  • Contact Info
  • Ariosa Diagnostics Inc.
    Phone: (408) 229-7500
    5945 Optical Ct.
    San Jose, CA 95138
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register